Pfizer Inc
NYSE: PFE
$29.50
+$0.19 (+0.6%)
Closing Price on September 24, 2024
PFE Articles
Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AbbVie Inc. (NYSE: ABBV) started as Neutral at Credit Suisse. Akamai...
Published:
ThinkstockCorporate governance issues are sometimes a blessing for shareholders, but they also can crush the rights of shareholders in many cases. Tracking CEO pay of large public companies is now...
Published:
ThinkstockZoetis Inc. (NYSE: ZTS), a spin-off of the animal health business of Pfizer Inc. (NYSE: PFE), held its initial public offering this morning. The company offered 86.1 million shares at $26 a...
Published:
Last Updated:
Jon OggThese are this Wednesday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Amazon.com Inc. (NASDAQ: AMZN) cut to Outperform at CLSA and maintained...
Published:
Last Updated:
U.S. equity markets opened slightly lower this morning following not-much in the way of new data and a wait-and-see attitude until tomorrow’s meeting announcement from the FOMC, which began a...
Published:
Last Updated:
U.S. equity markets opened mixed this morning on relatively little new data. In Europe, Italian consumer confidence rose more than expected and Germany auctioned 12-month bills at a positive yield...
Published:
Last Updated:
Frank Golhen, via Wikimedia CommonsEarnings season is in full swing and the coming week will have many big earnings announcements. 24/7 Wall St. has provided a brief calendar showing current and...
Published:
ThinkstockAfter a strong year of relative performance for pharmaceutical stocks in 2012, the analysts at Jefferies Group Inc. (NYSE: JEF) predict that 2013 could show more of the same. However they...
Published:
Last Updated:
courtesy of Apple Inc.Each January, 24/7 Wall St. forecasts the publicly traded U.S. companies that will have the highest profits in the year ahead. This year, Apple almost certainly will keep first...
Published:
Last Updated:
ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. If you look at the...
Published:
Last Updated:
As each new year arrives, 24/7 Wall St. looks at each of the 30 Dow Jones Industrial Average components and assigns a forward value for the Dow based on a mixed methodology. We have actually come...
Published:
Last Updated:
Frank Golhen, via Wikimedia CommonsThe Dogs of the Dow are measured out each year simply as the five highest common stock dividend yields among the Dow Jones Industrial Average’s 30 components. We...
Published:
Last Updated:
U.S. equity markets opened lower this morning following last night’s failure by the U.S. House of Representatives to hold a vote on a plan to deal with the country’s budget deficit. In Europe,...
Published:
Last Updated:
Thinkstock24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in 2012. If you look at the consensus price targets from analysts for the coming 12...
Published:
Last Updated:
ThinkstockOn December 7, marijuana became legal in the state of Washington, adding to the list of states that have moved toward legalizing or decriminalizing the drug. Will this be a national trend...
Published:
Last Updated: